content

Cipla and Kemwell Biopharma announce execution of a joint venture agreement for developing, manufacturing and commercialising biosimilars

Cipla Limited, a leading global pharmaceutical company and Kemwell Biopharma Private Limited, a leading biopharmaceutical Contract Development and Manufacturing Organisation (CDMO), announced execution of...

Quotient Sciences Invests in Drug Substance Manufacturing Facility

Quotient Sciences, a drug development and manufacturing company, is investing ยฃ6.3 million pounds ($8.6mn) in its recently acquired manufacturing facility in Alnwick, UK. The...

Innovent Biologics, Bolt Biotherapeutics Enter Immuno oncology Alliance

Innovent Biologics, Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines for cancer, metabolic, autoimmune and other diseases, and Bolt Biotherapeutics, Inc., a...

SK bioscience & GSK initiate phase 3 trial of adjuvanted Covid-19 vaccine candidate

SK bioscience (SK) and GlaxoSmithKline (GSK) announced the initiation of a phase 3 clinical study of SKโ€™s Covid-19 vaccine candidate, GBP510, in combination with...

Abbott introduces single-dose formulation of carbetocin for prevention of postpartum haemorrhage in India

Abbott, the global healthcare company has announced the introduction of a room-temperature-stable, single-dose formulation of carbetocin in India, which is available in convenient vials,...

Drug Substance Freezing and Why It Doesn’t Have To Be a Bottleneck

Drug substance freezing has moved on. Traditionally it was inefficient in a multitude of ways. Issues such as product loss, reduction of product potency, or...

Rapid Development and Industrialization of a COVID-19 Viral Vector Vaccine Manufacturing Process

The year 2020 will go down in history books as a year that changed the world and helped drug manufacturing to evolve. When the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read